Shareholders meeting

July 08, 2026 BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Exchange Plaza, Plot No. C/1, Dalal Street, G Block Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E) Mumbai- 400 051 Scrip Code-540025 Trading Symbol-ADVENZYMES Dear Sir/Madam, Sub: Notice of 37th Annual General Meeting of the Company Ref.: ISIN: INE837H01020 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) read with Schedule III thereto, please find enclosed the Notice convening 37th AGM of the Company scheduled to be held on Friday, July 31, 2026 at 10:00 a.m. (IST) through Video Conference (“VC”) or Other Audio Visual Means (“OAVM”). The aforesaid Notice of 37th AGM is also uploaded on the website of the Company, under the tab ‘Shareholder Meetings’: https://www.advancedenzymes.com/wp-content/uploads/2026/07/Notice-of-37th-Annual- General-Meeting.pdf This is for your information and for public at large. Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head-Legal Encl: As above NOTICE ADVANCED ENZYME TECHNOLOGIES LIMITED CIN: L24200MH1989PLC051018 Registered Office: 5th Floor, A-Wing, Sun Magnetica, LIC Service Road, Louiswadi, Thane (W) – 400604, Maharashtra, India Email: info@advancedenzymes.com, Website: www.advancedenzymes.com Tel.: +91-22-41703200; Fax: +91-22-25835159 NOTICE NOTICE is hereby given that the 37th (Thirty-Seventh) results and other certifications/scope of services, as Annual General Meeting (“AGM”) of the Members of may be mutually agreed and the Board of Directors of ADVANCED ENZYME TECHNOLOGIES LIMITED will be held the Company may decide in this behalf. on Friday, July 31, 2026 at 10:00 A.M. (IST) through Video RESOLVED FURTHER THAT the Board of Directors Conference (“VC”) / Other Audio Visual Means (“OAVM”), to of the Company or any Committee thereof be and is transact the following Business: hereby authorized to do all such acts, deeds and things Ordinary Business: as may be necessary to give effect to this resolution.” 1. To receive, consider and adopt the Audited Financial Special Business: Statements (Standalone) of the Company for the 5. Re-appointment of Mr. Mukund Madhusudan Kabra financial year ended March 31, 2026 together with the (DIN: 00148294) as a Whole-time Director of the Auditors’ report thereon and the report of the Board of Company Directors of the Company; and the Audited Financial Statements (Consolidated) of the Company for the To consider and if thought fit, to pass the following financial year ended March 31, 2026 together with the resolution as an Ordinary Resolution: Auditors’ report thereon. “ RESOLVED THAT pursuant to the provisions of Section 2. To declare final Dividend (` 1.35/- per 152, 196, 197, 203, Schedule V and other applicable Equity Share) on the Equity Shares of provisions, if any, of the Companies Act, 2013 read ` 2/- each, for the financial year ended March 31, 2026. with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 (including any 3. To appoint a Director in place of Ms. Rasika Rathi statutory modification(s) or re-enactments thereof for (DIN: 08300682), who retires by rotation and being the time being in force) and the Articles of Association eligible, offers herself for re-appointment as a Director. of the Company and based on the recommendation 4. To reappoint M/s. MSKA & Associates LLP of the Nomination and Remuneration Committee and (Firm Registration No. 105047W/W101187) (Formerly Board of Directors of the Company, approval of the known as MSKA & Associates) as the Statutory Members of the Company be and is hereby accorded Auditors of the Company and fix their remuneration for the re-appointment of Mr. Mukund Madhusudan Kabra (DIN: 00148294) as Whole-Time Director To consider and if thought fit, to pass the following (Key Managerial Personnel) of the Company for term of resolution as an Ordinary Resolution: 5 (Five) years with effect from April 01, 2027, liable “RESOLVED THAT pursuant to the provisions of to retire by rotation, as per the terms including the Section 139, 141, 142 and other applicable provisions, remuneration as mentioned in the Explanatory if any, of the Companies Act, 2013 read with the Statement. Companies (Audit and Auditors) Rules, 2014 (including RESOLVED FURTHER THAT the Board of Directors of any statutory modification(s) or re-enactments the Company and / or any Committee thereof be and thereof for the time being in force) and based on the is hereby authorised to settle any question, difficulty recommendations of the Audit Committee and the or doubts that may arise and to do all such acts, deeds Board of Directors of the Company, approval of the and things as may be necessary, usual, proper or Members be and is hereby accorded to reappoint expedient in this regard." M/s. MSKA & Associates LLP (Formerly known as MSKA & Associates), Chartered Accountants, 6. Appointment of Mr. Pradip Bhailal Shah (Firm Registration No. 105047W/W101187) as the (DIN: 01225582) as an Independent Director of the Statutory Auditors of the Company for a second term of Company 5 (Five) consecutive years, from the conclusion of this To consider and if thought fit, to pass the following 37th Annual General Meeting of the Company (“AGM”) Resolution as a Special Resolution: until the conclusion of 42nd AGM, at such remuneration plus applicable taxes and actual out of pocket “RESOLVED THAT pursuant to the provisions of expenses, if any, in connection with the Statutory Section 149, 150, 152 and Schedule IV of Companies Audit/Limited Review of the financial statements/ Act, 2013, corresponding rules framed thereunder and such other provisions as may be applicable (“Act”), IINNTTEEGGRRAATTEEDD AANNNNUUAALL RREEPPOORRTT 22002255--2266 read with the provisions of Regulation 17, 25 and in the Explanatory Statement, with liberty to the Board other applicable provisions, if any, of the Securities of Directors (including the Committees of the Board) to and Exchange Board of India (Listing Obligations and vary, amend or revise the remuneration and the terms Disclosure Requirements) Regulations, 2015 (including and conditions of her office in accordance with the any statutory modification(s) or re-enactment(s) provisions of the Act, as may be agreed to between the thereof for the time being in force), the Explanatory Board of Directors and Ms. Manasi Kabra. Statement annexed to the Notice convening the RESOLVED FURTHER THAT the Board of Directors of 37th Annual General Meeting of the Company, and the Company and / or any Committee thereof be and upon the recommendation of the Nomination and is hereby authorised to settle any question, difficulty Remuneration Committee and the Board of Directors, or doubts that may arise and to do all such acts, deeds approval of the Members of the Company be and is and things as may be necessary, usual, proper or hereby accorded for the appointment of Mr. Pradip expedient in this regard." Bhailal Shah (DIN: 01225582), who was appointed as an Additional Director (Independent) with effect from 8. Approval of Material Related Party Transactions with June 12, 2026, as an Independent Director on the JC Biotech Private Limited, Subsidiary Board of the Company, not liable to retire by rotation, To consider and if thought fit, to pass the following and to hold office for a period of 5 (Five) consecutive resolution as an Ordinary Resolution: years from June 12, 2026 to June 11, 2031 and in respect of whom the Company has received a Notice "RESOLVED THAT pursuant to the provisions of in writing from a Member under Section 160 of the Section 188(1) and other applicable provisions, if any, Act, signifying the intention of the said Member to of the Companies Act, 2013, read with the Companies propose the candidature of Mr. Pradip Bhailal Shah (Meetings of Board and its Powers) Rules, 2014 and (D [Showing first 8,000 characters — download PDF for full document]